Artificial intelligence for infection surveillance, risk stratification, and antimicrobial decision support in acute-care hospitals: a scoping review
Abstract
Background: Artificial intelligence (AI) has increasingly been proposed to strengthen infection surveillance, early risk stratification, antimicrobial decision support, and selected workflow functions in acute-care hospitals. However, the literature remains clinically heterogeneous, methodologically uneven, and conceptually fragmented, with technical performance often interprested too readily as evidence of clinical effectiveness. This scoping review aimed to map and synthesise the empirical literature on AI applications for infection surveillance and related hospital applications, while explicitly distinguishing technical performance from clinical utility, implementation relevance, and patient benefit.
Methods: We conducted a scoping review in accordance with PRISMA 2020 and PRISMA-ScR guidance. CINAHL, Cochrane Library, Embase, PubMed, Scopus, and Web of Science were searched for English-language empirical studies. Eligible studies examined AI applications relevant to infection surveillance, risk prediction, detection, antimicrobial decision support, or workflow-relevant hospital functions in acute-care settings. Findings were synthesised narratively by application domain and translational stage.
Results: Database searches yielded 884 records; 628 unique records underwent title and abstract screening, 180 full texts were assessed, and 39 studies were included. The literature was dominated by retrospective model-development and validation studies; no randomised trials or…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.